Europe · Regional markets · Option Finance

Diabète et obésité : le Retatrutide d'Eli Lilly surpasse l'Ozempic en phase 3

Published by Option Finance · France 2 h ago

Read the full article on Option Finance Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (news.google.com)

Also worth reading

Aston Martin unveils £1.3m open-top Valhalla Spider as supercar helps to narrow the British firm's losses

Investors Chronicle

Revolution Beauty’s losses narrow but challenges remain

HSBC increases profit by 32 percent — share price falls sharply

Who is Stefano Pessina, the dealmaker behind Boots’ sale?

Présidentielle 2027 : Gabriel Attal veut investir 200 milliards d'euros dans l'IA et le quantique

UBS dégage un bénéfice net de 2,7 milliards de dollars au troisième trimestre